The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma

Cell

Volumn 147, Issue 3, 2011, Pages 554-564

  Oricchio, Elisa ^a   Nanjangud, Gouri ^a,d   Wolfe, Andrew L ^a,b   Schatz, Jonathan H ^a,c   Mavrakis, Konstantinos J ^a   Jiang, Man ^a   Liu, Xiaoping ^a   Bruno, Joanne ^a   Heguy, Adriana ^a   Olshen, Adam B ^a,e   Socci, Nicholas D ^a   Teruya Feldstein, Julie ^a   Weis Garcia, Frances ^a   Tam, Wayne ^b   Shaknovich, Rita ^c   Melnick, Ari ^c   Himanen, Juha P ^a   Chaganti, R S K ^a   Wendel, Hans Guido ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Weill Cornell/Rockefeller/Sloan Kettering Tri Institutional MD PhD Program ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR A7; RITUXIMAB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN VARIANT;

MURINAE;

EID: 80155148301     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2011.09.035     Document Type: Article

References (68)

1. P.M. Barr, and H.M. Lazarus Follicular non-Hodgkin lymphoma: long-term results of stem-cell transplantation Curr. Opin. Oncol. 20 2008 502 508
2. R.J. Bende, L.A. Smit, and C.J. van Noesel Molecular pathways in follicular lymphoma Leukemia 21 2007 18 29 (Pubitemid 44921830)
3. N. Bidere, V.N. Ngo, J. Lee, C. Collins, L. Zheng, F. Wan, R.E. Davis, G. Lenz, D.E. Anderson, and D. Arnoult Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival Nature 458 2009 92 96
4. D.P. Calado, B. Zhang, L. Srinivasan, Y. Sasaki, J. Seagal, C. Unitt, S. Rodig, J. Kutok, A. Tarakhovsky, and M. Schmidt-Supprian Constitutive canonical NF-kappaB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma Cancer Cell 18 2010 580 589
5. L. Chin, and J.W. Gray Translating insights from the cancer genome into clinical practice Nature 452 2008 553 563 (Pubitemid 351483369)
6. M. Compagno, W.K. Lim, A. Grunn, S.V. Nandula, M. Brahmachary, Q. Shen, F. Bertoni, M. Ponzoni, M. Scandurra, and A. Califano Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma Nature 459 2009 717 721
7. D.W. Dawson, J.S. Hong, R.R. Shen, S.W. French, J.J. Troke, Y.Z. Wu, S.S. Chen, D. Gui, M. Regelson, and Y. Marahrens Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas Oncogene 26 2007 4243 4252 (Pubitemid 46975800)
8. R.A. Dickins, M.T. Hemann, J.T. Zilfou, D.R. Simpson, I. Ibarra, G.J. Hannon, and S.W. Lowe Probing tumor phenotypes using stable and regulated synthetic microRNA precursors Nat. Genet. 37 2005 1289 1295 (Pubitemid 41568715)
9. L. Ding, G. Getz, D.A. Wheeler, E.R. Mardis, M.D. McLellan, K. Cibulskis, C. Sougnez, H. Greulich, D.M. Muzny, and M.B. Morgan Somatic mutations affect key pathways in lung adenocarcinoma Nature 455 2008 1069 1075
10. A. Egle, A.W. Harris, M.L. Bath, L. O'Reilly, and S. Cory VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia Blood 103 2004 2276 2283 (Pubitemid 38326247)
11. D.M. Feldser, K.K. Kostova, M.M. Winslow, S.E. Taylor, C. Cashman, C.A. Whittaker, F.J. Sanchez-Rivera, R. Resnick, R. Bronson, and M.T. Hemann Stage-specific sensitivity to p53 restoration during lung cancer progression Nature 468 2010 572 575
12. G. Gaidano, R.S. Hauptschein, N.Z. Parsa, K. Offit, P.H. Rao, G. Lenoir, D.M. Knowles, R.S. Chaganti, and R. Dalla-Favera Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma Blood 80 1992 1781 1787
13. R.S. Hauptschein, B. Gamberi, P.H. Rao, F. Frigeri, L. Scotto, V.S. Venkatraj, G. Gaidano, T. Rutner, Y.H. Edwards, and R.S. Chaganti Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types Genomics 50 1998 170 186 (Pubitemid 28303511)
14. J. Heyer, L.N. Kwong, S.W. Lowe, and L. Chin Non-germline genetically engineered mouse models for translational cancer research Nat. Rev. Cancer 10 2010 470 480
15. J.P. Himanen, L. Yermekbayeva, P.W. Janes, J.R. Walker, K. Xu, L. Atapattu, K.R. Rajashankar, A. Mensinga, M. Lackmann, and D.B. Nikolov Architecture of Eph receptor clusters Proc. Natl. Acad. Sci. USA 107 2010 10860 10865
16. J. Holmberg, D.L. Clarke, and J. Frisen Regulation of repulsion versus adhesion by different splice forms of an Eph receptor Nature 408 2000 203 206
17. N.A. Johnson, K.J. Savage, O. Ludkovski, S. Ben-Neriah, R. Woods, C. Steidl, M.J. Dyer, R. Siebert, J. Kuruvilla, and R. Klasa Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival Blood 114 2009 2273 2279
18. M. Kato, M. Sanada, I. Kato, Y. Sato, J. Takita, K. Takeuchi, A. Niwa, Y. Chen, K. Nakazaki, and J. Nomoto Frequent inactivation of A20 in B-cell lymphomas Nature 459 2009 712 716
19. U. Klein, and R. Dalla-Favera Germinal centres: role in B-cell physiology and malignancy Nat. Rev. Immunol. 8 2008 22 33
20. S.Q. Kuang, H. Bai, Z.H. Fang, G. Lopez, H. Yang, W. Tong, Z.Z. Wang, and G. Garcia-Manero Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia Blood 115 2010 2412 2419
21. G. Lenz, R.E. Davis, V.N. Ngo, L. Lam, T.C. George, G.W. Wright, S.S. Dave, H. Zhao, W. Xu, and A. Rosenwald Oncogenic CARD11 mutations in human diffuse large B cell lymphoma Science 319 2008 1676 1679 (Pubitemid 351432507)
22. M. Macrae, R.M. Neve, P. Rodriguez-Viciana, C. Haqq, J. Yeh, C. Chen, J.W. Gray, and F. McCormick A conditional feedback loop regulates Ras activity through EphA2 Cancer Cell 8 2005 111 118 (Pubitemid 41132740)
23. D.G. Maloney Rituximab for follicular lymphoma Curr. Hematol. Rep. 2 2003 13 22
24. J. Mandelbaum, G. Bhagat, H. Tang, T. Mo, M. Brahmachary, Q. Shen, A. Chadburn, K. Rajewsky, A. Tarakhovsky, and L. Pasqualucci BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma Cancer Cell 18 2010 568 579
25. K.J. Mavrakis, A.L. Wolfe, E. Oricchio, T. Palomero, K. de Keersmaecker, K. McJunkin, J. Zuber, T. James, A.A. Khan, and C.S. Leslie Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia Nat. Cell Biol. 12 2010 372 379
26. K.M. McBride, A. Gazumyan, E.M. Woo, T.A. Schwickert, B.T. Chait, and M.C. Nussenzweig Regulation of class switch recombination and somatic mutation by AID phosphorylation J. Exp. Med. 205 2008 2585 2594
27. A.P. McCaffrey, L. Meuse, T.T. Pham, D.S. Conklin, G.J. Hannon, and M.A. Kay RNA interference in adult mice Nature 418 2002 38 39 (Pubitemid 34742563)
28. G. Nanjangud, P.H. Rao, J. Teruya-Feldstein, G. Donnelly, J. Qin, S. Mehra, S.C. Jhanwar, A.D. Zelenetz, and R.S. Chaganti Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression Cytogenet. Genome Res. 118 2007 337 344 (Pubitemid 350125274)
29. V.N. Ngo, R.M. Young, R. Schmitz, S. Jhavar, W. Xiao, K.H. Lim, H. Kohlhammer, W. Xu, Y. Yang, and H. Zhao Oncogenically active MYD88 mutations in human lymphoma Nature 470 2011 115 119
30. N.K. Noren, G. Foos, C.A. Hauser, and E.B. Pasquale The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway Nat. Cell Biol. 8 2006 815 825 (Pubitemid 44151584)
31. U. Novak, A. Rinaldi, I. Kwee, S.V. Nandula, P.M. Rancoita, M. Compagno, M. Cerri, D. Rossi, V.V. Murty, and E. Zucca The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas Blood 113 2009 4918 4921
32. K. Offit, N.Z. Parsa, G. Gaidano, D.A. Filippa, D. Louie, D. Pan, S.C. Jhanwar, R. Dalla-Favera, and R.S. Chaganti 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma Blood 82 1993 2157 2162 (Pubitemid 23294000)
33. E. Oricchio, A.L. Wolfe, J.H. Schatz, K.J. Mavrakis, and H.G. Wendel Mouse models of cancer as biological filters for complex genomic data Dis. Model Mech. 11-12 2010 701 704
34. E.B. Pasquale Eph-ephrin bidirectional signaling in physiology and disease Cell 133 2008 38 52 (Pubitemid 351442996)
35. E.B. Pasquale Eph receptors and ephrins in cancer: bidirectional signalling and beyond Nat. Rev. Cancer 10 2010 165 180
36. L. Pasqualucci, M. Compagno, J. Houldsworth, S. Monti, A. Grunn, S.V. Nandula, J.C. Aster, V.V. Murty, M.A. Shipp, and R. Dalla-Favera Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma J. Exp. Med. 203 2006 311 317 (Pubitemid 43290840)
37. T. Relander, N.A. Johnson, P. Farinha, J.M. Connors, L.H. Sehn, and R.D. Gascoyne Prognostic factors in follicular lymphoma J. Clin. Oncol. 28 2010 2902 2913
38. R. Schmitz, M.L. Hansmann, V. Bohle, J.I. Martin-Subero, S. Hartmann, G. Mechtersheimer, W. Klapper, I. Vater, M. Giefing, and S. Gesk TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma J. Exp. Med. 206 2009 981 989
39. E. Seiradake, K. Harlos, G. Sutton, A.R. Aricescu, and E.Y. Jones An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly Nat. Struct. Mol. Biol. 17 2010 398 402
40. A.L. Shaffer, N.C. Emre, L. Lamy, V.N. Ngo, G. Wright, W. Xiao, J. Powell, S. Dave, X. Yu, and H. Zhao IRF4 addiction in multiple myeloma Nature 454 2008 226 231 (Pubitemid 351969894)
41. F.M. Smith, C. Vearing, M. Lackmann, H. Treutlein, J. Himanen, K. Chen, A. Saul, D. Nikolov, and A.W. Boyd Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen J. Biol. Chem. 279 2004 9522 9531 (Pubitemid 38296020)
42. D.M. Valenzuela, E. Rojas, J.A. Griffiths, D.L. Compton, M. Gisser, N.Y. Ip, M. Goldfarb, and G.D. Yancopoulos Identification of full-length and truncated forms of Ehk-3, a novel member of the Eph receptor tyrosine kinase family Oncogene 10 1995 1573 1580
43. V.E. Velculescu Defining the blueprint of the cancer genome Carcinogenesis 29 2008 1087 1091 (Pubitemid 351958685)
44. A. Ventura, D.G. Kirsch, M.E. McLaughlin, D.A. Tuveson, J. Grimm, L. Lintault, J. Newman, E.E. Reczek, R. Weissleder, and T. Jacks Restoration of p53 function leads to tumour regression in vivo Nature 445 2007 661 665 (Pubitemid 46232887)
45. A. Viardot, P. Moller, J. Hogel, K. Werner, G. Mechtersheimer, A.D. Ho, G. Ott, T.F. Barth, R. Siebert, and S. Gesk Clinicopathologic correlations of genomic gains and losses in follicular lymphoma J. Clin. Oncol. 20 2002 4523 4530 (Pubitemid 35402955)
46. H.G. Wendel, E. De Stanchina, J.S. Fridman, A. Malina, S. Ray, S. Kogan, C. Cordon-Cardo, J. Pelletier, and S.W. Lowe Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy Nature 428 2004 332 337 (Pubitemid 38418805)
47. W. Xue, L. Zender, C. Miething, R.A. Dickins, E. Hernando, V. Krizhanovsky, C. Cordon-Cardo, and S.W. Lowe Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Nature 445 2007 656 660 (Pubitemid 46232886)
48. L. Zender, W. Xue, J. Zuber, C.P. Semighini, A. Krasnitz, B. Ma, P. Zender, S. Kubicka, J.M. Luk, and P. Schirmacher An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer Cell 135 2008 852 864
49. Antipenko, A., Himanen, J.P., van Leyen, K., Nardi-Dei, V., Lesniak, J., Barton, W.A., Rajashankar, K.R., Lu, M., Hoemme, C., Puschel, A.W., et al. (2003). Structure of the semaphorin-3A receptor binding module. Neuron 39, 589-598.
50. Bergers, G., Javaherian, K., Lo, K.M., Folkman, J., and Hanahan, D. (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812.
51. Chen, K., McLellan, M.D., Ding, L., Wendl, M.C., Kasai, Y., Wilson, R.K., and Mardis, E.R. (2007). PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data. Genome Res. 17, 659-666.
52. Dickins, R.A., Hemann, M.T., Zilfou, J.T., Simpson, D.R., Ibarra, I., Hannon, G.J., and Lowe, S.W. (2005). Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37, 1289-1295.
53. Egle, A., Harris, A.W., Bath, M.L., O'Reilly, L., and Cory, S. (2004). VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103, 2276-2283.
54. Gordon, D., Abajian, C., and Green, P. (1998). Consed: a graphical tool for sequence finishing. Genome Res. 8, 195-202.
55. Himanen, J.P., Henkemeyer, M., and Nikolov, D.B. (1998). Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2. Nature 396, 486-491.
56. Mandelbaum, J., Bhagat, G., Tang, H., Mo, T., Brahmachary, M., Shen, Q., Chadburn, A., Rajewsky, K., Tarakhovsky, A., Pasqualucci, L., et al. (2010). BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell Lymphoma. Cancer Cell 18, 568-579.
57. Mavrakis, K.J., Wolfe, A.L., Oricchio, E., Palomero, T., de Keersmaecker, K., McJunkin, K., Zuber, J., James, T., Khan, A.A., Leslie, C.S., et al. (2010). Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T cell acute lymphoblastic leukemia. Nat. Cell Biol. 12, 372-379.
58. Mavrakis, K.J., Zhu, H., Silva, R.L., Mills, J.R., Teruya-Feldstein, J., Lowe, S.W., Tam, W., Pelletier, J., and Wendel, H.G. (2008). Tumorigenic activity and therapeutic inhibition of Rheb GTPase. Genes Dev. 22, 2178-2188.
59. McBride, K.M., Gazumyan, A., Woo, E.M., Schwickert, T.A., Chait, B.T., and Nussenzweig, M.C. (2008). Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med. 205, 2585-2594.
60. Nickerson, D.A., Tobe, V.O., and Taylor, S.L. (1997). PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25, 2745-2751.
61. Scott, C.L., Gil, J., Hernando, E., Teruya-Feldstein, J., Narita, M., Martinez, D., Visakorpi, T., Mu, D., Cordon-Cardo, C., Peters, G., et al. (2007). Role of the chromobox protein CBX7 in lymphomagenesis. Proc. Natl. Acad. Sci. USA 104, 5389-5394.
62. Shaknovich, R., Figueroa, M.E., and Melnick, A. (2010). HELP (HpaII tiny fragment enrichment by ligation-mediated PCR) assay for DNA methylation profiling of primary normal and malignant B lymphocytes. Methods Mol. Biol. 632, 191-201.
63. Thompson, R.F., Reimers, M., Khulan, B., Gissot, M., Richmond, T.A., Chen, Q., Zheng, X., Kim, K., and Greally, J.M. (2008). An analytical pipeline for genomic representations used for cytosine methylation studies. Bioinformatics 24, 1161-1167.
64. Veeriah, S., Taylor, B.S., Meng, S., Fang, F., Yilmaz, E., Vivanco, I., Janakiraman, M., Schultz, N., Hanrahan, A.J., Pao, W., et al. (2010). Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet. 42, 77-82.
65. Wendel, H.G., de Stanchina, E., Cepero, E., Ray, S., Emig, M., Fridman, J.S., Veach, D.R., Bornmann, W.G., Clarkson, B., McCombie, W.R., et al. (2006). Loss of p53 impedes the antileukemic response to BCR-ABL inhibition. Proc. Natl. Acad. Sci. USA 103, 7444-7449.
66. Wendel, H.G., De Stanchina, E., Fridman, J.S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., and Lowe, S.W. (2004). Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428, 332-337.
67. Xu, K., Rajashankar, K.R., Chan, Y.P., Himanen, J.P., Broder, C.C., and Nikolov, D.B. (2008). Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc. Natl. Acad. Sci. USA 105, 9953-9958.
68. Yu, D., and Thomas-Tikhonenko, A. (2002). A non-transgenic mouse model for B cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Oncogene 21, 1922-1927.